Back to top
more

Select Medical (SEM)

(Delayed Data from NYSE)

$34.18 USD

34.18
2,367,199

-5.00 (-12.76%)

Updated Aug 2, 2024 04:00 PM ET

After-Market: $34.18 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 31% (78 out of 251)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Magellan Health's PBM Division Unveils Care Management Plan

by Zacks Equity Research

Magellan Health's (MGLN) pharmacy benefit management division's newly-launched plan is expected to drive value-added healthcare.

Humana, Epione Tie Up to Aid Medicare Advantage Members

by Zacks Equity Research

Humana (HUM) inks deal with Epione Health of Oklahoma to provide better patient care.

UnitedHealth Group to Enhance its Medicare Advantage Network

by Zacks Equity Research

UnitedHealth Group (UNH) partners Walgreens to provide better access to MA members.

Why is HCA Healthcare an Attractive Stock for Your Portfolio?

by Zacks Equity Research

Growing revenues and a strong capital position bode well for HCA Healthcare (HCA).

The Zacks Analyst Blog Highlights: Jounce Therapeutics, BioDelivery Sciences International, Ironwood Pharmaceuticals, Osmotica Pharmaceuticals and Select Medical

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Jounce Therapeutics, BioDelivery Sciences International, Ironwood Pharmaceuticals, Osmotica Pharmaceuticals and Select Medical

Why Should You Hold Universal Health in Your Portfolio?

by Zacks Equity Research

Banking on its growing top line and strong segments, Universal Health (UHS) holds potential to reap benefits for investors.

Sweta Killa headshot

Healthcare Sector Outperforming: 5 Best ETFs & Stocks QTD

by Sweta Killa

Healthcare bounced back with an outperformance starting the fourth quarter.

Humana (HUM) to Boost Medicare Advantage Network in Hawaii

by Zacks Equity Research

Humana (HUM) teams up with Hawaii Senior Medical Group to enrich patient experience of Medicare Advantage members in the region.

Humana (HUM) Scales New 52-Week High on Solid Q3 Earnings

by Zacks Equity Research

Humana (HUM) reaches a 52-week high, backed by strong-third-quarter results and Medicare business.

UnitedHealth (UNH) Looks Good: Stock Adds 5.3% in Session

by Zacks Equity Research

UnitedHealth (UNH) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

The Zacks Analyst Blog Highlights: McGrath RentCorp, FTI Consulting, Huron Consulting, Select Medical and Tenet Healthcare

by Zacks Equity Research

The Zacks Analyst Blog Highlights: McGrath RentCorp, FTI Consulting, Huron Consulting, Select Medical and Tenet Healthcare

Nalak Das headshot

ISM Services Index Rebounds in October: 5 Top-Ranked Picks

by Nalak Das

The ISM Services index clearly reflects that the U.S. economy has sustained its momentum despite lingering trade conflict and global economic slowdown.

Select Medical (SEM) Surpasses Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Select Medical (SEM) delivered earnings and revenue surprises of 50.00% and 4.64%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Select Medical (SEM) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Select Medical (SEM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Select Medical (SEM) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Select Medical (SEM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Select Medical (SEM) Matches Q4 Earnings Estimates

by Zacks Equity Research

Select Medical (SEM) delivered earnings and revenue surprises of 0.00% and -0.92%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Select Medical (SEM) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Select Medical (SEM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Weakness Seen in Select Medical Holdings (SEM) Estimates: Should You Stay Away?

by Zacks Equity Research

Select Medical Holdings (SEM) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.

Select Medical (SEM) Tops Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Select Medical (SEM) delivered earnings and revenue surprises of 27.78% and 0.12%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

Select Medical (SEM) Q3 Earnings Preview: What's Shaping Up?

by Zacks Equity Research

Select Medical (SEM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Select Medical (SEM) Misses Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Select Medical (SEM) delivered earnings and revenue surprises of -13.89% and -0.57%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

    Select Medical (SEM) Q1 Earnings and Revenues Top Estimates

    by Zacks Equity Research

    Select Medical's (SEM) first-quarter results find support in bottom-line growth, higher revenues and solid segmental performances. However, rise in expenses is a downside.

      Will Cigna (CI) Beat Q1 Earnings Estimates This Time Again?

      by Zacks Equity Research

      Cigna (CI) Q1 earnings to see upside from higher revenues, enrollment growth.

        Should Value Investors Pick Select Medical Holdings (SEM) Stock?

        by Zacks Equity Research

        Select Medical Holdings (SEM) is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front.

          4 Health Care Stocks Set to Beat Earnings Estimates in 4Q

          by Zacks Equity Research

          This attractive sector has several companies with upside potential.